ReViral

Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Fierce Biotech
Thu, 04/7/22 - 10:29 am
Pfizer
RSV
M&A
ReViral
ReViral Completes $55 Million Series B Round to Advance RSV Treatment
CP Wire
Wed, 08/1/18 - 10:45 am
ReViral
RSV
RV521
ReViral Completes $55 Million Series B Round to Advance RSV Treatment
Wed, 08/1/18 - 10:35 am
ReViral